ARCHIVES

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Also in this 8-page issue: Use cancer mortality, not 5-year survival, to track progress against cancer, researchers say.

July 29, 2005

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983